Frame Mary D, Rivers Richard J, Altland Owen, Cameron Scott
Department of Biomedical Engineering, Stony Brook University, HSC T18-030, Stony Brook, NY 11794-8181, USA.
J Appl Physiol (1985). 2007 Jun;102(6):2279-87. doi: 10.1152/japplphysiol.00537.2006. Epub 2007 Mar 22.
Our purpose was to investigate the local mechanisms involved in network-wide flow and diameter changes observed with localized downstream vitronectin receptor ligation; we tested specific K or Cl channels known to be involved in either dilation or elevated permeability following vitronectin receptor activation and tested integrin-linked pathway elements of tyrosine phosphorylation and protein kinase C (PKC). Arteriolar networks were observed in the cheek pouch tissue of anesthetized (pentobarbital sodium, 70 mg/kg) hamsters (n=86) using intravital microscopy. Terminal arteriolar branches of the networks were stimulated with micropipette LM609 (0.5-10 microg/ml, 60 s) alone or with inhibitors (separate micropipette). Hemodynamic changes (diameter, red blood cell flux, velocity) were observed at the upstream entrance to the network. LM609 alone stimulated first an increase in wall shear stress (WSS), followed by a dilation that recovered WSS to baseline or below. K channel inhibition (glybenclamide, 4-AP) had no effect on the initial peak in WSS, but decreased remote vasodilation. Cl channel inhibition (DIDS, IAA-94, niflumic acid) or inhibition of PKC (chelerythrine) prevented the initial peak in WSS and decreased remote vasodilation. Inhibition of tyrosine phosphorylation (genistein) prevented both. With the use of nitro-arginine at the observation site, the initial peak in WSS was not affected, but remote vasodilation was decreased. We conclude the remote response consists of an initial peak in WSS that relies on both PKC activity and depolarization downstream, leading to an upstream flow mediated dilation and a secondary remote dilation that relies on hyperpolarization downstream at the stimulus site; both components require tyrosine phosphorylation downstream.
我们的目的是研究局部下游玻连蛋白受体连接时所观察到的全网络血流和直径变化涉及的局部机制;我们测试了已知在玻连蛋白受体激活后参与扩张或通透性升高的特定钾通道或氯通道,并测试了酪氨酸磷酸化和蛋白激酶C(PKC)的整合素连接途径元件。使用活体显微镜在麻醉(戊巴比妥钠,70mg/kg)仓鼠(n = 86)的颊囊组织中观察小动脉网络。用微量移液器单独给予LM609(0.5 - 10μg/ml,60秒)或与抑制剂(单独的微量移液器)刺激网络的终末小动脉分支。在网络的上游入口处观察血流动力学变化(直径、红细胞通量、速度)。单独使用LM609首先刺激壁面剪应力(WSS)增加,随后是扩张,使WSS恢复到基线或更低水平。钾通道抑制(格列本脲、4 - AP)对WSS的初始峰值无影响,但减少了远处血管扩张。氯通道抑制(DIDS、IAA - 94、氟尼酸)或PKC抑制(白屈菜红碱)阻止了WSS的初始峰值并减少了远处血管扩张。酪氨酸磷酸化抑制(染料木黄酮)两者均能阻止。在观察部位使用硝基精氨酸时,WSS的初始峰值不受影响,但远处血管扩张减少。我们得出结论,远处反应包括WSS的初始峰值,其依赖于下游的PKC活性和去极化,导致上游血流介导的扩张以及依赖于刺激部位下游超极化的继发性远处扩张;两个组成部分都需要下游的酪氨酸磷酸化。